The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10159128" target="_blank" >RIV/00216208:11110/13:10159128 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/13:10159128 RIV/00216208:11120/13:43907495 RIV/00216208:11160/13:10159128 RIV/62157124:16370/13:43872380 RIV/00023728:_____/14:#0003046

Výsledek na webu

<a href="http://link.springer.com/article/10.1007/s00296-012-2542-x/fulltext.html" target="_blank" >http://link.springer.com/article/10.1007/s00296-012-2542-x/fulltext.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00296-012-2542-x" target="_blank" >10.1007/s00296-012-2542-x</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008

Popis výsledku v původním jazyce

To investigate the burden of ankylosing spondylitis in the Czech Republic as a baseline for future health economic evaluations. Data were obtained from two cross-sectional studies Beda I (2005) and Beda II (2008), performed in 1,008 and 509 patients, respectively. Methodology used was Cost-of-Illness prevalence-based analysis bottom-up approach. Analysis was performed from payer (health insurance companies) and societal perspective (including productivity costs using friction cost approach). Mean age ofsample in Beda I and Beda II was 50.2 and 52.5 years, male were present by 61.0 and 62.7 %; average disease duration was 23.0 and 26.4 years, respectively. Mean total annual costs per patient in the sample were Euro4,782 in Beda I and Euro5806 in Beda II. Average direct costs per patient in the sample per year are estimated at Euro1,812 (Beda I) and Euro2,588 (Beda II) with the average productivity costs Euro2,970 (Beda I) and Euro3,218 (Beda II). We observed a small decrement in percen

Název v anglickém jazyce

The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008

Popis výsledku anglicky

To investigate the burden of ankylosing spondylitis in the Czech Republic as a baseline for future health economic evaluations. Data were obtained from two cross-sectional studies Beda I (2005) and Beda II (2008), performed in 1,008 and 509 patients, respectively. Methodology used was Cost-of-Illness prevalence-based analysis bottom-up approach. Analysis was performed from payer (health insurance companies) and societal perspective (including productivity costs using friction cost approach). Mean age ofsample in Beda I and Beda II was 50.2 and 52.5 years, male were present by 61.0 and 62.7 %; average disease duration was 23.0 and 26.4 years, respectively. Mean total annual costs per patient in the sample were Euro4,782 in Beda I and Euro5806 in Beda II. Average direct costs per patient in the sample per year are estimated at Euro1,812 (Beda I) and Euro2,588 (Beda II) with the average productivity costs Euro2,970 (Beda I) and Euro3,218 (Beda II). We observed a small decrement in percen

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Rheumatology International

ISSN

0172-8172

e-ISSN

—

Svazek periodika

33

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

1813-1819

Kód UT WoS článku

000321259500022

EID výsledku v databázi Scopus

—